The treatment of SKOV3 and OVCAR3 ovarian cancer cells with the STAT3 ODN-decoy led to decreased invasive cancer potential and increased cell sensitivity to paclitaxel [169]. The gene discussed is STAT3; the disease is ovarian cancer.